IBD Teams with Innovator Capital Management to Help Investors Learn to Profit from IBD 50 ETF Index

Webinar comes as Morningstar ranks Innovator IBD 50 the Best Performing ETF of 2017 in the Mid-Cap Growth category

LOS ANGELES, Oct. 23, 2017 (GLOBE NEWSWIRE) -- Investor’s Business Daily (IBD), a leading financial news and research organization, today announced its latest webinar, How to Profit from the IBD 50 ETF Index. This exclusive, free webinar brings together two of IBD’s leading voices-- Chief Content Officer Chris Gessel and Market Research Director Justin Nielsen -- with Bruce Bond, CEO of Innovator Capital Management. Together they will share the latest insights into profiting from the IBD 50 and other market-trouncing IBD indexes. This can’t miss discussion takes place on Wednesday, October 25, 2017 at 1:30pm Pacific/4:30pm Eastern.

For many years, IBD 50 has been the go-to list for top growth stocks. In this webinar, Gessel, Nielsen, and Bond will go in-depth with the IBD 50 and examine why it works. They will also explain how and why IBD teamed up with Innovator—a leader in the ETF field—to create the first ETF that tracks the IBD 50. The resulting ETF,  Innovator IBD 50, was recently ranked by Morningstar as the Best Performing ETF of 2017 year-to-date. Gessel, Nielsen, and Bond will also discuss how weighting and market timing affect the IBD 50 from an ETF perspective.

“Education is fundamental to all that IBD seeks to accomplish. We are incredibly excited for this webinar so that we can provide investors with really unique, data-driven information that can guide their investment strategies and decisions,” said Gessel. “And investors will learn some amazing things from Bruce. He is one of the leading lights in ETFs so this is a great opportunity for investors to get all of their questions answered.”

IBD is known for its unique commentary and analysis on the stock market, proprietary data, and investing research, as well as for its commitment to educate investors at all levels. Its webinars are simply one example. IBD also offers individual and professional investors a comprehensive lineup of Digital products and a weekly print publication, all based on an independently-tested investment discipline that has dramatically outperformed the S&P 500.

To sign up for How to Profit from the IBD 50 ETF Index, please visit: investors.com/webinar. For additional IBD webinars, covering a broad range of investing topics, go to http://www.investors.com/category/ibd-videos/ibd-webinars/.

About IBD
Investor's Business Daily is a leading financial news and research organization recognized for proprietary stock screens, comparative performance ratings and a record of identifying stock leaders as they emerge. The company takes a data-first approach to investing, educating investors about how to invest successfully using tested methods and sound research. IBD has honed its approach over the last 50 years to help investors make smarter decisions. Its stock lists have outperformed the S&P, and its recent presidential poll, the most accurate over the past four election cycles, was one of only two national polls to accurately predict the outcome of the 2016 Presidential Election. IBD offers a number of interactive stock research tools and information for investors of every level. To learn more about all that IBD has available, please visit www.investors.com.

For Editorial Contact:
Marisa Lam
GMK Communications for IBD